Skip to main content

Cervical Cancer Screening

CBE ID
0032
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
Next Maintenance Cycle
Spring 2026
1.6 Measure Description

The percentage of women 21–64 years of age who were screened for cervical cancer using either of the following criteria:
-Women 21–64 years of age who had cervical cytology performed within the last 3 years.
-Women 30–64 years of age who had cervical high-risk human papillomavirus (hrHPV) testing performed within the last 5 years.
-Women 30–64 years of age who had cervical cytology/high-risk human papillomavirus (hrHPV) cotesting within the last 5 years.

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      1.8 Level of Analysis
      1.20 Types of Data Sources
      1.14 Numerator

      The number of women who were screened for cervical cancer.

      1.15 Denominator

      Women 24-64 years of age as of the end of the measurement year.

      Exclusions

      This measure excludes women who had a hysterectomy with no residual cervix, cervical agenesis or acquired absence of cervix any time during their medical history through the end of the measurement year.

      Most Recent Endorsement Activity
      Endorsed Prevention and Population Health Spring Cycle 2020
      Initial Endorsement
      Last Updated
      Steward Organization
      National Committee for Quality Assurance
      Steward POC email
      measureendorsement@ncqa.org
      Steward Organization Copyright

      © 2020 by the National Committee for Quality Assurance
      1100 13th Street, NW, 3rd floor
      Washington, DC 20005

                Public Comments